chapter 22- Hemostasis and Thrombosis Flashcards
what is the mechanism of action of aspirin
inhibit platelet cyclooxyrgenase, thereby blocking thromboxane A2 generation and inhibiting platelet granule release reaction and platelet aggregation
what is the mechanism of action of dipyridamole
inhibit platelet cAMP degradation and thereby decrease platelet aggregability
what is the mechanism of action of ticlopidine, clopidogrel, and prasugrel
covalently modify platelet ADP receptor, thereby preventing receptor signaling and irreversibly inhibiting ADP-dependent platelet activation pathway
what is the mechanism of action of eptifibatide, abciximab, tirofiban
bind to platelet receptor GPIIb-IIIa and thereby prevent binding of fibrinogen and other adhesive ligands
what is the mechanism of action of warfarin
inhibit hepatic epoxide reductase that catalyzes the regeneration of reduced vitamin K
what is the mechanism of action of unfractionated heparin
combines with antithrombin III and inhibits secondary hemostasis via nonselective inactivation of thrombin, factor Xa, factor XIa, and factor XIIa
what is the mechanism of action of LMW heparins
combine with antithrombin III and inhibit secondary hemostasis via relatively selective inactivation of factor Xa
what is the mechanism of action of fondaparinux
combine with antithrombin III and inhibit secondary hemostasis via highly selective inactivation of factor Xa
what is the mechanism of action of hirudin-related agents (lepirudin, desirudin, bivalirudin) and argatroban
bind directly to thrombin and thereby inhibit secondary hemostasis
what is the mechanism of action of recombinant activated protein C
proteolytically inactivates factors Va and VIIa
what drugs are genetically engineered variants of t-PA with increased specificity for fibrin
tenecteplase, reteplase
what is the mechanism of action of protamine
inactivates heparin by forming a stable 1:1 protamine: heparin compelx
what is the mechanism of action of aprotinin
inhibits serine proteases, including plasmin, t-PA, and thrombin
what is the mechanism of action of aminocaproic acid, tranexamic acid
analogues of lysine that bind to and inhibit plasminogen and plasmin
what is the clinical application of aspirin
prophylaxis against transient ischemic attach, MI and thromboembolic strokes
what are some adverse effects seen with aspirin
GI bleeding, acute renal insufficiency, reyes syndrome, tinnitus
what are some contraindications for aspirin use
G6Pd deficiency, children with chickenpox or flu-like symptoms
what is the clinical application of dipyridamole
prophylaxis against thromboembolic disorders, alternative to exercise in thallium myocardial perfusion imaging
what are some adverse effects seen specific with IV route dipyridamole
exacerbation of aging, hypotension
what is dipyridamole usually administered in combination with
aspirin or warfarin
how may dipyridamole paradoxically induce angina
by causing coronary steal phenomenon
what is the clinical application of ticlopidine
secondary prevention of thrombin strokes in patients intolerant of aspirin
what are some adverse effects seen with ticlopidine
aplastic anemia, abnormal LFT
what are some contraindications for ticlopidine use
active bleeding disorder, severe liver dysfunction
what is the major contraindication for clopidogrel use
active bleeding disorder